A federal judge has formally dismissed the remaining criminal case against four leaders of the Proud Boys who were previously convicted of seditious conspiracy for their roles in the January 6, 2021, attack on the U.S. Capitol. U.S. District Judge Timothy Kelly, a Trump appointee, issued the order on Friday, stating that the law left him no choice but to grant the Department of Justice's request to end the prosecution. The decision marks the final chapter in a landmark legal battle that had already been significantly altered by presidential action.
In January 2025, President Donald Trump issued a sweeping executive order granting clemency to approximately 1,500 individuals involved in the Capitol riot. While that order commuted the prison sentences of Proud Boys leaders Ethan Nordean, Joseph Biggs, Zachary Rehl, and Dominic Pezzola, their underlying convictions remained on the books. Following a request from the Department of Justice, an appeals court vacated those convictions earlier this year, clearing the path for Friday's dismissal.
Judge Kelly, who presided over the original trial, noted in his seven-page ruling that there was little mystery regarding the administration's motivation for abandoning the case. He emphasized that his decision was rooted in the separation of government powers rather than the merits of the case itself. He maintained that the Capitol riot was a perilous event that threatened the peaceful transfer of power, but concluded that denying the government's motion would not serve a practical purpose given the current legal landscape.
The dismissal is with prejudice, meaning the charges cannot be brought against these individuals again. This ruling effectively closes the book on one of the most significant prosecutions stemming from the January 6 investigation. As the legal system adjusts to these changes, the focus now shifts to the broader implications of the administration's policy toward those involved in the Capitol attack and the long-term impact on the judicial precedents established during the initial trials.